Amanote Research
Register
Sign In
Correction: TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-Cell Persistence and Rejection of Established Tumors
Cancer Research
- United States
doi 10.1158/0008-5472.can-17-1193
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 14, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Dual Blockade of PD-1 and CTLA-4 Combined With Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors—Response
Cancer Research
Cancer Research
Oncology
P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Rapid Tumor Induction in Zebrafish by TALEN-mediated Somatic Inactivation of the Retinoblastoma1 Tumor Suppressor Rb1
Scientific Reports
Multidisciplinary
SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells
Immunity
Infectious Diseases
Allergy
Immunology
MA11.01 Comparative Efficacy of T-Cell Intrinsic Versus Extrinsic PD-1 Blockade to Overcome PD-L1+ Tumor-Mediated Exhaustion
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-L1 Mediated the Differentiation of Tumor-Infiltrating CD19+B Lymphocytes and T Cells in Invasive Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells
Clinical Cancer Research
Cancer Research
Oncology
Tumor-Infiltrating T Cells and PD-L1 Expression in Childhood Malignant Extracranial Germ-Cell Tumors
OncoImmunology
Oncology
Allergy
Immunology
Perfluorocarbon Nanoparticle-Mediated Platelet Inhibition Promotes Intratumoral Infiltration of T Cells and Boosts Immunotherapy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
